Showing results (421-430 of 607) with videos related to
Sort By:
Pageof 61
International Journal of Radiation Oncology, Biology, Physics|May 27, 2008
The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositisDavid I Rosenthal, Tito R Mendoza, Mark S Chambers, et al.Seminars in Oncology|February 1, 1997
Intensive radiation therapy concurrent with up to 7-week continuous-infusion paclitaxel for locally advanced solid tumors: phase I studiesD I Rosenthal, O Okani, J M Truelson, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapyAlexander F Bagley, Rong Ye, Adam S Garden, et al.Cancer|March 29, 2016
Radiation therapy (with or without neck surgery) for phenotypic human papillomavirus-associated oropharyngeal cancerAdam S Garden, Clifton D Fuller, David I Rosenthal, et al.Head & Neck|March 16, 2007
Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck moduleDavid I Rosenthal, Tito R Mendoza, Mark S Chambers, et al.Blood|May 5, 2010
A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1Elena Lukina, Nora Watman, Elsa Avila Arreguin, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|August 9, 2014
Nomogram for predicting symptom severity during radiation therapy for head and neck cancerTommy Sheu, Clifton David Fuller, Tito R Mendoza, et al.International Journal of Radiation Oncology, Biology, Physics|July 1, 2018
Significance of Negative Posttreatment 18-FDG PET/CT Imaging in Patients With p16/HPV-Positive Oropharyngeal CancerSweet Ping Ng, Jason M Johnson, G Brandon Gunn, et al.International Journal of Radiation Oncology, Biology, Physics|March 11, 2015
Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522David L Schwartz, Jonathan Harris, Min Yao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neckD I Rosenthal, J H Lee, R Sinard, et al.Pageof 61